UNSPSC 51422104: Diflucortolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28F2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K253365DXI, chemically known as 6alpha,9-difluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione but generally known as diflucortolone, which bears US NIH Compound Identifier 17455. European Medicines Agency schedules Diflucortolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07128MIG.

UNSPSC 51422104 Diflucortolone is a Commodity code, but the recent state and local opportunities posted under it show minimal alignment with the code's nominal pharmaceutical scope. The two most recent solicitations — one from Seminole County, Florida for naloxone and drug deactivation systems, and one from the Texas Health and Human Services Commission for therapeutic pharmacy initiative direct-to-manufacturer prescriptions — involve naloxone procurement and pharmacy benefit management infrastructure rather than diflucortolone (a topical corticosteroid). State and local governments appear to be tagging broad pharmaceutical and medical-supply acquisitions under this code without precision, suggesting either a classification drift or an issuing-body misunderstanding of UNSPSC tier boundaries.

The Seminole County opportunity (IFB 60459723LAS, due July 26, 2023) represents a concrete medical-supply procurement: 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries required to a county community health building and bidders responsible for shipping. The Texas HHS Commission RFI (HHS0017013, posted April 3, 2026) is a pre-RFP market intelligence exercise exploring vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, with no award value or formal timeline specified at the inquiry stage. Geographic activity concentrates in Florida and Texas based on recent posts; no other states appear in the opportunities block. Because the posted solicitations do not procure diflucortolone itself, this code shows little actionable recent activity for vendors supplying the pharmaceutical product as described.